Search for: "Astrazeneca"
Results 401 - 420
of 1,244
Sort by Relevance
|
Sort by Date
2 Jun 2015, 7:19 am
A medical panel of the US Food and Drug Administration (FDA) has recommended the agency require new warning labels for two diabetes drugs: Onglyza manufactured by AstraZeneca and Nesina by Takeda Pharmaceuticals. [read post]
1 Jun 2015, 3:33 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 47 [week ending on Sunday 24 May] - Nicolas Sarkozy and the IP | Another reference on TM licences to the CJEU | UPC test-drive | Swatch v Swatchball | New Lisbon Treaty on appellations of origin and geographical indications | UP reneal fees | Synthon v Teva | GC on Yoshida | UPC Court fees event | EPO staff under fire | The trade-secret option | Damages |AstraZeneca AB & Another v KRKA dd… [read post]
1 Jun 2015, 12:36 pm
They might be right — Pfizer and AstraZeneca are facing multiple lawsuits over Lipitor and Crestor, respectively, about their lack of sufficient diabetes warnings by statin users who contracted the disease. [read post]
1 Jun 2015, 10:29 am
The lawsuit alleged that Medco and AstraZeneca entered into hidden financial agreements based on which Medco received lower prices on three AstraZeneca drugs in exchange for including one of AstraZeneca’s medications as the only one of its kind on some of Medco’s list of covered prescriptions. [read post]
25 May 2015, 4:15 am
, Paul Inman and Ailsa Carter, have summarised last week's decision from the Court of Appeal in AstraZeneca AB & Another v KRKA dd Novo Mesto & Another [2015] EWCA Civ 484.* F1 ends up in hot water - no similarity to F1H2OIn Case T-55/13 the General Court of the European Union deals with Formula One Licensing BV's opposition against Idea Marketing SA’s Community trade mark application for 'F1H2O'. [read post]
22 May 2015, 10:38 am
Since AstraZeneca's Nexium was sold in tablets, prescribing practice would need to have changed in order for the Emozul capsules to be dispensed, so AstraZeneca contended that market penetration would have been relatively modest. [read post]
21 May 2015, 7:10 am
Bloomberg News reports that the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended that the agency “add data from trials on the heart effects to the labels of” two diabetes drugs: AstraZeneca’s Onglyza (saxagliptin) and Takeda’s Nesina (alogliptin). [read post]
18 May 2015, 5:55 am
.' Astrazeneca AB v. [read post]
17 May 2015, 6:28 am
3M, however, lives on in the continuing failure of all attempts at legislative correction to produce laws consistent with the approach taken in the rest of the developed world.In the latest chapter of this ongoing saga, on the 13th and 14th of May the Australian High Court heard oral arguments in the appeal by pharmaceutical company AstraZeneca AB against last year’s ruling of an expanded five-judge Full Bench of the Federal Court of Australia that its two patents relating to… [read post]
14 May 2015, 4:00 am
In the past five years, the Canadian Federal Court has invalidated several patents based on an arguably “technical” deficiency – the “Promise/utility” requirement. [read post]
30 Apr 2015, 9:35 am
Now, AstraZeneca has filed a notice-of-removal of the state court lawsuit to Federal Court. [read post]
29 Apr 2015, 11:07 am
Perdue supposedly used a pitch in that effort that was written by an AstraZeneca employee. [read post]
16 Apr 2015, 9:59 pm
As set forth in the opinion, AstraZeneca's lawsuit against Apotex was part of the "second wave" of ANDA litigation, wherein the District Court apportioned into two sets of four defendants from the eight ANDA filers sued by AstraZeneca in the Southern District of New York starting at the end of the last century. [read post]
13 Apr 2015, 2:51 pm
As regards what that FDA staff document contained and its significance, from an April 10, 2015 Bloomberg news report, "AstraZeneca’s Diabetes Drug May Raise Death Risk, FDA Says": AstraZeneca Plc’s type 2 diabetes drug Onglyza showed an increased risk of death in an analysis by U.S. regulators of a clinical trial on the heart effects of the treatment. [read post]
13 Apr 2015, 3:00 am
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]
13 Apr 2015, 3:00 am
There’s been a lot of positive activity in recent months for Bristol-Myers Squibb of New York City. [read post]
7 Apr 2015, 11:49 am
We previously affirmedthe district court’s decision in an earlier phase of the samelitigation holding that Apotex had infringed certainpatents held by AstraZeneca AB and related parties(collectively, “Astra”). [read post]
7 Apr 2015, 10:24 am
Astrazeneca v. [read post]
23 Mar 2015, 2:55 pm
Both of these FDA letters, to AstraZeneca and to Novo Nordisk respectively, contain this paragraph: We also refer to our letter dated October 7, 2014, notifying you, under Section 505(o)(4) of the FDCA, of new safety information that we believe should be included in the labeling for long-acting GLP-1 receptor agonist products. [read post]
9 Mar 2015, 1:46 pm
These Two New AstraZeneca Diabetes Medications With Saxagliptin Are Part Of The Incretin Mimetic Class Of Drugs (Posted by Tom Lamb at DrugInjuryWatch.com)At an April 14, 2015 meeting of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee, results of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) trial for for AstraZeneca's relatively new diabetes drugs Onglyza… [read post]
